Sultan Ismail Hospital is a hospital in Taman Mount Austin, Johor Bahru, Johor, Malaysia. The hospital is named in honour of Sultan Ismail of Johor. The hospital was equipped with a computerised system and all administrative work and transactions would go through the system.

There are 704 beds in Hospital Sultan Ismail.

During the past decade, Hospital Sultan Ismail conducted 20 clinical trials. In the 10-year time frame, 20 clinical trials started and 3 clinical trials were completed, i.e. on average, 15% percent of trials that started reached the finish line to date. In the past 5 years, 15 clinical trials started and 3 clinical trials were completed. i.e. 20% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Hospital Sultan Ismail" #1 sponsor was "Janssen Research & Development, LLC" with 6 trials, followed by "Boehringer Ingelheim" with 4 trials sponsored, "National University of Malaysia" with 2 trials sponsored, "TauRx Therapeutics Ltd" with 2 trials sponsored and "Arcus Biosciences, Inc." with 2 trials sponsored. Other sponsors include 1 different institutions and companies that sponsored additional 11 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Hospital Sultan Ismail" #1 collaborator was "Gilead Sciences" with 1 trials as a collaborator and "NanoCarrier Co., Ltd." with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "Hospital Sultan Ismail" are "Generalized Pustular Psoriasis" (3 trials), "Alzheimer's Disease" (2 trials), "Carcinoma, Non-Small-Cell Lung" (2 trials), "Non-Small Cell Lung Cancer" (2 trials) and "PreDiabetes" (2 trials). Many other conditions were trialed in "Hospital Sultan Ismail" in a lesser frequency.

Most popular intervention types in "Hospital Sultan Ismail" are "Drug" (19 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (7 trials), "Spesolimab" (3 trials), "Amivantamab" (2 trials), "Carboplatin" (2 trials) and "Niraparib" (2 trials). Other intervention names were less common.

The vast majority of trials in "Hospital Sultan Ismail" are 18 trials for "All" genders, 2 trials for "Male" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Hospital Sultan Ismail". undefined are not yet recruiting, 7 are recruiting, 5 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 7 completed trials in Hospital Sultan Ismail, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Hospital Sultan Ismail, 3 "Phase 1" clinical trials were conducted, 5 "Phase 2" clinical trials and 11 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 1 trials that are defined as “Not Applicable".